UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Magnetic Nanoparticles in Medical Diagnostic Applications: Synthesis, Characterization and Proteins Conjugation

Current nanoscience, 2016-08, Vol.12 (4), p.455-468

2016

Volltextzugriff (PDF)

The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective

The oncologist (Dayton, Ohio), 2010-11, Vol.15 (S4), p.5-13

2010

Volltextzugriff (PDF)

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study

Journal of hepatology, 2016-12, Vol.65 (6), p.1140-1147

2016

Volltextzugriff (PDF)

Targeting neuroendocrine prostate cancer: molecular and clinical perspectives

Frontiers in oncology, 2015-02, Vol.5, p.6-6

2015

Volltextzugriff (PDF)

The Impact of Enhanced Recovery after Surgery Protocol Implementation on Postoperative Pain Management in the Era of Opioid Crisis: The Postchemotherapy Open RPLND Experience

Current cancer drug targets, 2023-12, Vol.23 (11), p.910-916

2023

Volltextzugriff (PDF)

Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells

Journal of molecular medicine (Berlin, Germany), 2012, Vol.90 (1), p.45-54

2012

Volltextzugriff (PDF)

Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model

International journal of oncology, 2019-02, Vol.54 (2), p.537-549

2019

Volltextzugriff (PDF)

Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2108-2121

2004

Volltextzugriff (PDF)

Prostate cancer: ESMO Consensus Conference Guidelines 2012

Annals of oncology, 2013-05, Vol.24 (5), p.1141-1162

2013

Volltextzugriff (PDF)

The ubiquitin-proteasome system in prostate cancer and its transition to castration resistance

Urologic oncology, 2012-11, Vol.30 (6), p.752-761

2012

Volltextzugriff (PDF)

Early mRNA Expression of Neuroendocrine Differentiation Signals Predicts Recurrence After Radical Prostatectomy: A Transcriptomic Analysis

World journal of oncology, 2021-12, Vol.12 (6), p.232-239

2021

Volltextzugriff (PDF)

Bortezomib as a potential treatment for prostate cancer

Cancer research (Chicago, Ill.), 2004-08, Vol.64 (15), p.5036-5043

2004

Volltextzugriff (PDF)

Revisiting bleomycin from pathophysiology to safe clinical use

Critical reviews in oncology/hematology, 2013-07, Vol.87 (1), p.90-100

2013

Volltextzugriff (PDF)

Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosis

Lung cancer (Amsterdam, Netherlands), 2011-12, Vol.74 (3), p.516-520

2011

Volltextzugriff (PDF)

Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study)

Current oncology (Toronto), 2021-12, Vol.28 (6), p.5266-5277

2021

Volltextzugriff (PDF)

Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner

Investigational new drugs, 2013-10, Vol.31 (5), p.1169-1181

2013

Volltextzugriff (PDF)

Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis

Supportive care in cancer, 2012-08, Vol.20 (8), p.1823-1829

2012

Volltextzugriff (PDF)

The ubiquitin-proteasome system in glioma cell cycle control

Cell division, 2012-07, Vol.7 (1), p.18-18

2012

Volltextzugriff (PDF)

Predicting VLCC fuel consumption with machine learning using operationally available sensor data

Ocean engineering, 2022-01, Vol.243, p.110321, Article 110321

2022

Volltextzugriff (PDF)

Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

Journal of neuro-oncology, 2017-09, Vol.134 (2), p.443-451

2017

Volltextzugriff (PDF)

The prognostic significance of the Hedgehog signaling pathway in colorectal cancer

Clinical colorectal cancer, 2016-06, Vol.15 (2), p.116-127

2016

Volltextzugriff (PDF)

Results of a Phase II Study With Doxorubicin, Etoposide, and Cisplatin in Patients With Fully Characterized Small-Cell Carcinoma of the Prostate

Journal of clinical oncology, 2002-07, Vol.20 (14), p.3072-3080

2002

Volltextzugriff (PDF)

Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer

Archivio italiano di urologia, andrologia, 2021-06, Vol.93 (2), p.143-147

2021

Volltextzugriff (PDF)

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Magnetic Nanoparticles in Medical Diagnostic Applications: Synthesis, Characterization and Proteins Conjugation

The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study

Targeting neuroendocrine prostate cancer: molecular and clinical perspectives

The Impact of Enhanced Recovery after Surgery Protocol Implementation on Postoperative Pain Management in the Era of Opioid Crisis: The Postchemotherapy Open RPLND Experience

Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells

Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer

Prostate cancer: ESMO Consensus Conference Guidelines 2012

The ubiquitin-proteasome system in prostate cancer and its transition to castration resistance

Early mRNA Expression of Neuroendocrine Differentiation Signals Predicts Recurrence After Radical Prostatectomy: A Transcriptomic Analysis

Bortezomib as a potential treatment for prostate cancer

Revisiting bleomycin from pathophysiology to safe clinical use

Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosis

Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study)

Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner

Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis

The ubiquitin-proteasome system in glioma cell cycle control

Predicting VLCC fuel consumption with machine learning using operationally available sensor data

Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental

The prognostic significance of the Hedgehog signaling pathway in colorectal cancer

Results of a Phase II Study With Doxorubicin, Etoposide, and Cisplatin in Patients With Fully Characterized Small-Cell Carcinoma of the Prostate

Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer

Suchergebnisse filtern